Challenges to vaccinating adolescents: vaccine implementation issues
- PMID: 15931141
- DOI: 10.1097/01.inf.0000166161.12087.94
Challenges to vaccinating adolescents: vaccine implementation issues
Abstract
Background: Adolescent immunization is a growing field, with many new vaccines in development and new or expanded immunization recommendations on the horizon.
Methods: Characteristics of adolescents and their health care are discussed, focusing specifically on the challenges of incorporating a potential recommendation to replace tetanus-diphtheria toxoid with tetanus-diphtheria-acellular pertussis vaccine during early or middle adolescence as part of routine preventive care. Using the framework created by the Centers for Disease Control and Prevention's Task Force on Community Preventive Services, three overlapping levels at which there are opportunities for vaccine intervention are reviewed: (1) health care systems (enhancing access to vaccination services); (2) health care providers (provider-based interventions); and (3) patients and families ("increasing community demand").
Results: There are several barriers to vaccine implementation that make achieving high immunization coverage rates among adolescents a challenge. Promising interventions for improving vaccination rates at the health care system level include reducing out-of-pocket costs, expanding access to immunizations, and implementing vaccination programs in schools. Provider-based interventions for improving vaccination rates include regular assessments of immunization rate with feedback to all office personnel, provider reminders, and standing orders. Client recall and reminders, education, and requirements for school entry can assist in "increasing community demand" for vaccinations in that they motivate parents and adolescents to follow through with immunizations.
Conclusions: Adolescents are unique from other populations. Previously studied interventions need to be tested in this age group as immunization becomes a more salient issue in adolescent health care.
Similar articles
-
Impact of tetanus, diphtheria, and acellular pertussis (Tdap) vaccine use in wound management on health care costs and pertussis cases.J Manag Care Spec Pharm. 2015 Jan;21(1):88-99, 99a-c. doi: 10.18553/jmcp.2015.21.1.88. J Manag Care Spec Pharm. 2015. PMID: 25562776
-
A quality improvement initiative to increase Tdap (tetanus, diphtheria, acellular pertussis) vaccination coverage among direct health care providers at a children's hospital.Vaccine. 2018 Jan 4;36(2):214-219. doi: 10.1016/j.vaccine.2017.11.071. Epub 2017 Dec 6. Vaccine. 2018. PMID: 29217370
-
Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.Pediatrics. 2006 Mar;117(3):965-78. doi: 10.1542/peds.2005-3038. Epub 2005 Dec 28. Pediatrics. 2006. PMID: 16382131
-
Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): a review of evidences and recommendations.Vaccine. 2012 Jul 27;30(35):5179-90. doi: 10.1016/j.vaccine.2012.06.005. Epub 2012 Jun 15. Vaccine. 2012. PMID: 22709953 Review.
-
Understanding barriers and predictors of maternal immunization: Identifying gaps through an exploratory literature review.Vaccine. 2018 Nov 26;36(49):7445-7455. doi: 10.1016/j.vaccine.2018.10.046. Epub 2018 Oct 28. Vaccine. 2018. PMID: 30377064 Review.
Cited by
-
Meningococcal Disease in Pediatric Age: A Focus on Epidemiology and Prevention.Int J Environ Res Public Health. 2022 Mar 29;19(7):4035. doi: 10.3390/ijerph19074035. Int J Environ Res Public Health. 2022. PMID: 35409716 Free PMC article.
-
COVID-19 and Routine Childhood and Adolescent Immunizations: Evidence from Louisiana Medicaid.Vaccine. 2022 Feb 7;40(6):837-840. doi: 10.1016/j.vaccine.2021.12.022. Epub 2021 Dec 24. Vaccine. 2022. PMID: 35033386 Free PMC article.
-
Easy access to vaccination was important for adherence during the 2016-2019 HPV catch-up vaccination in Norway.Hum Vaccin Immunother. 2022 Dec 31;18(1):1971921. doi: 10.1080/21645515.2021.1971921. Epub 2021 Oct 6. Hum Vaccin Immunother. 2022. PMID: 34613857 Free PMC article.
-
The find of COVID-19 vaccine: Challenges and opportunities.J Infect Public Health. 2021 Mar;14(3):389-416. doi: 10.1016/j.jiph.2020.12.025. Epub 2020 Dec 30. J Infect Public Health. 2021. PMID: 33647555 Free PMC article. Review.
-
Why the Anti-Meningococcal B Vaccination during Adolescence Should Be Implemented in Italy: An Overview of Available Evidence.Microorganisms. 2020 Oct 29;8(11):1681. doi: 10.3390/microorganisms8111681. Microorganisms. 2020. PMID: 33138142 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
